Sign in

CIK 0001790340

  • Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
  1. 4 Open-market buy Director bought 4,750 shares at $24.45 ($116,114)
  2. 4 Open-market buy Director bought 6,099 shares at an average $21.50 ($131,114)
  3. 4 Open-market buy PRESIDENT AND CEO bought 2,083 shares at $22.87 ($47,632)
  4. 3/A Insider 3/A
  5. 4 Open-market buy Former 10% Owner bought 550,000 shares at $15.00 ($8,250,000)
  6. 4 Open-market buy Director bought 291,667 shares at $15.00 ($4,375,005)
  7. 4 Open-market buy President and CEO bought 2,098 shares at $15.00 ($31,470)
  8. 4 Open-market buy Director bought 7,000 shares at $15.00 ($105,000)
  9. 4 Open-market buy Chief Scientific Officer bought 1,353 shares at $15.00 ($20,295)
  10. 4 Open-market buy Director bought 325,000 shares at $15.00 ($4,875,000)
  11. 4 Open-market buy General Counsel and Secretary bought 1,402 shares at $15.00 ($21,030)
  12. 4 Open-market buy Director bought 3,500 shares at $15.00 ($52,500)
  13. 4 Open-market buy Chief Medical Officer bought 667 shares at $15.00 ($10,005)
  14. 4 Open-market buy CFO, Treasurer bought 4,175 shares at $15.00 ($62,625)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 8 of 9 · 166 filings